tiprankstipranks

Masaru Matsuda Insider Profile

11 Followers
Masaru Matsuda, Reporting Person's title: EVP, CLO at Arcutis Biotherapeutics, holds 116.18K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 20.05K shares in Halozyme (Ticker: HALO).
tipranks
Masaru Matsuda

Masaru Matsuda
Arcutis Biotherapeutics (ARQT)
Reporting Person's title: EVP, CLO

Ranked #105,773 out of 109,030 Corporate Insiders

Profitable Transactions

40%
6 out of 15 Profitable Transactions

Average Return

-56.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
56.58%
43.42%
A breakdown of Masaru Matsuda's holdings

Insider Roles

Arcutis Biotherapeutics
(ARQT)
Reporting Person's title: EVP, CLO
Halozyme
(HALO)
SVP & GC
Roles that Masaru Matsuda holds in companies

Most Profitable Insider Trade

Stock:
Arcutis Biotherapeutics
(ARQT)
Rating:Informative Sell
Date:Nov 22, 2022 - Nov 22, 2023
Return:+89.70%
The most profitable trade made by Masaru Matsuda

Masaru Matsuda's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arcutis Biotherapeutics
Sep 10, 2026
Reporting Person's title: EVP, CLO
Uninformative Sell
249.92K
$2.82M
Halozyme
Sep 07, 2021
SVP & GC
Uninformative Buy
146.55K
$2.16M
List of latest transactions for each holding click on a transaction to see Masaru Matsuda's performance on stock

Masaru Matsuda insider profile FAQ

What is the percentage of profitable transactions made by Masaru Matsuda?
The percentage of profitable transactions made by Masaru Matsuda is 40%.
    What is the average return per transaction made by Masaru Matsuda?
    The average return per transaction made by Masaru Matsuda is -56.70%.
      What stocks does Masaru Matsuda hold?
      Masaru Matsuda holds: ARQT, HALO stocks.
        What was Masaru Matsuda’s latest transaction?
        Masaru Matsuda latest transaction was an Uninformative Sell of $249.92K.
          What was Masaru Matsuda's most profitable transaction?
          Masaru Matsuda’s most profitable transaction was an Informative Sell of ARQT stock on November 22, 2022. The return on the trade was 89.70%.
            What is Masaru Matsuda's role in Arcutis Biotherapeutics?
            Masaru Matsuda's role in Arcutis Biotherapeutics is Reporting Person's title: EVP, CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.